Invizius Company

Invizius offers extra-corporeal treatments for patients that includes dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. Invizius develops H-Guard, an advanced hemocompatible coating capable of preventing foreign body reactions in the blood at the source. Invizius aims to revolutionize dialysis and other extracorporeal treatments.

Founded Date: 2017
Headquarters: Edinburgh, Edinburgh, City of, United Kingdom
Technology: Other
Employee Number: Undisclosed
Industry: Preventive Medicine
Number Of Exists: N/A
Funding Status: Seed
Investor Type: N/A
Investment Stage: N/A